HomeCompareLNTQF vs MRK

LNTQF vs MRK: Dividend Comparison 2026

LNTQF yields 7.55% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 LNTQF wins by $71630.44M in total portfolio value
10 years
LNTQF
LNTQF
● Live price
7.55%
Share price
$49.48
Annual div
$3.74
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$71630.50M
Annual income
$69,854,193,771.77
Full LNTQF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — LNTQF vs MRK

📍 LNTQF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodLNTQFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, LNTQF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
LNTQF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

LNTQF
Annual income on $10K today (after 15% tax)
$642.14/yr
After 10yr DRIP, annual income (after tax)
$59,376,064,706.00/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, LNTQF beats the other by $59,376,056,377.59/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of LNTQF + MRK for your $10,000?

LNTQF: 50%MRK: 50%
100% MRK50/50100% LNTQF
Portfolio after 10yr
$35815.28M
Annual income
$34,927,101,784.96/yr
Blended yield
97.52%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

LNTQF
No analyst data
Altman Z
-0.1
Piotroski
4/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

LNTQF buys
0
MRK buys
0
No recent congressional trades found for LNTQF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricLNTQFMRK
Forward yield7.55%2.76%
Annual dividend / share$3.74$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%32.7%
Portfolio after 10y$71630.50M$56.8K
Annual income after 10y$69,854,193,771.77$9,798.13
Total dividends collected$71508.91M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: LNTQF vs MRK ($10,000, DRIP)

YearLNTQF PortfolioLNTQF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$12,211$1,510.93$11,206$366.19+$1.0KLNTQF
2$16,514$3,448.56$12,650$502.35+$3.9KLNTQF
3$26,388$8,717.56$14,407$694.19+$12.0KLNTQF
4$54,272$26,036.67$16,585$967.82+$37.7KLNTQF
5$158,163$100,092.40$19,342$1,363.89+$138.8KLNTQF
6$714,464$545,229.66$22,913$1,947.19+$691.6KLNTQF
7$5,368,114$4,603,637.46$27,662$2,823.89+$5.34MLNTQF
8$70,396,878$64,652,995.65$34,159$4,173.35+$70.36MLNTQF
9$1,660,095,724$1,584,771,064.50$43,337$6,308.80+$1660.05MLNTQF
10$71,630,496,196$69,854,193,771.77$56,776$9,798.13+$71630.44MLNTQF

LNTQF vs MRK: Complete Analysis 2026

LNTQFStock

Leonteq AG provides structured investment products and long-term savings and retirement solutions in Switzerland and internationally. It operates through Investment Solutions and Insurance & Wealth Planning Solutions segments. The company manufactures and distributes structured investment products. It also offers savings, investment, and drawdown products; and digital platform that enables unit-linked retail products with financial guarantees, as well as hedging for structured products. The company offers its services to platform partners under the terms of cooperation agreements, as well as distributes its products to retail investors through institutional and financial intermediaries. The company was formerly known as EFG Financial Products Holding AG and changed its name to Leonteq AG in June 2013. Leonteq AG was incorporated in 2007 and is headquartered in Zurich, Switzerland.

Full LNTQF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this LNTQF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

LNTQF vs SCHDLNTQF vs JEPILNTQF vs OLNTQF vs KOLNTQF vs MAINLNTQF vs JNJLNTQF vs ABBVLNTQF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.